OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
3.970
+0.060 (1.53%)
At close: Dec 20, 2024, 4:00 PM
3.790
-0.180 (-4.53%)
After-hours: Dec 20, 2024, 7:20 PM EST
OS Therapies Employees
As of December 31, 2022, OS Therapies had 4 total employees, including 3 full-time and 1 part-time employees.
Employees
4
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,854,693
Market Cap
84.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EDAP TMS | 307 |
| Century Therapeutics | 165 |
| OptimizeRx | 136 |
| LENSAR | 130 |
| Fractyl Health | 102 |
| Coya Therapeutics | 8 |
| Context Therapeutics | 5 |
| Anixa Biosciences | 5 |
OSTX News
- 5 weeks ago - OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 6 weeks ago - OS Therapies to Present at The Spartan Capital Investor Conference - Business Wire
- 7 weeks ago - Join OS Therapies' Exclusive Live Investor Webinar and Q&A Session on October 30 - Business Wire
- 7 weeks ago - OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors - Business Wire
- 2 months ago - OS Therapies to Present at the LD Micro Main Event XVII - Business Wire
- 2 months ago - OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - Business Wire
- 2 months ago - OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit - Business Wire
- 3 months ago - OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates - Business Wire